Heat Biologics Signs a Research License Agreement with ProBioGen for Transposase System and Suspension HEK293 Cell Line

Shots:

  • ProBioGen collaborates with Heat Biologics for both ProBioGen’s DirectedLuck Transposase System along with suspension HEK293 cell line
  • The DirectedLuck Transposase is well-matched with additional genetic elements in standard expression vector design and can be used with any host cell line
  • ProBioGen’s HEK293 has been developed for the manufacture of proteins and viral vectors and is distinguished through robust growths in a chemically defined medium in suspension culture to make it a valuable tool for production in large bioreactors

Click here to read full press release/ article | Ref: ProBioGen | Image: ProBioGen

The post Heat Biologics Signs a Research License Agreement with ProBioGen for Transposase System and Suspension HEK293 Cell Line first appeared on PharmaShots.